These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 24143237)

  • 1. Imaging the L-type amino acid transporter-1 (LAT1) with Zr-89 immunoPET.
    Ikotun OF; Marquez BV; Huang C; Masuko K; Daiji M; Masuko T; McConathy J; Lapi SE
    PLoS One; 2013; 8(10):e77476. PubMed ID: 24143237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transport of 3-fluoro-L-α-methyl-tyrosine by tumor-upregulated L-type amino acid transporter 1: a cause of the tumor uptake in PET.
    Wiriyasermkul P; Nagamori S; Tominaga H; Oriuchi N; Kaira K; Nakao H; Kitashoji T; Ohgaki R; Tanaka H; Endou H; Endo K; Sakurai H; Kanai Y
    J Nucl Med; 2012 Aug; 53(8):1253-61. PubMed ID: 22743251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. System L amino acid transporter LAT1 accumulates O-(2-fluoroethyl)-L-tyrosine (FET).
    Habermeier A; Graf J; Sandhöfer BF; Boissel JP; Roesch F; Closs EI
    Amino Acids; 2015 Feb; 47(2):335-44. PubMed ID: 25385314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative immunoPET of prostate cancer xenografts with 89Zr- and 124I-labeled anti-PSCA A11 minibody.
    Knowles SM; Zettlitz KA; Tavaré R; Rochefort MM; Salazar FB; Stout DB; Yazaki PJ; Reiter RE; Wu AM
    J Nucl Med; 2014 Mar; 55(3):452-9. PubMed ID: 24504052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immuno-PET Imaging of CD30-Positive Lymphoma Using 89Zr-Desferrioxamine-Labeled CD30-Specific AC-10 Antibody.
    Rylova SN; Del Pozzo L; Klingeberg C; Tönnesmann R; Illert AL; Meyer PT; Maecke HR; Holland JP
    J Nucl Med; 2016 Jan; 57(1):96-102. PubMed ID: 26514172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amino acid transporter LAT1 (SLC7A5) as a molecular target for cancer diagnosis and therapeutics.
    Kanai Y
    Pharmacol Ther; 2022 Feb; 230():107964. PubMed ID: 34390745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A radiopharmaceutical [
    Tang Y; Hu Y; Liu W; Chen L; Zhao Y; Ma H; Yang J; Yang Y; Liao J; Cai J; Chen Y; Liu N
    Nucl Med Biol; 2019 Mar; 70():23-31. PubMed ID: 30826708
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Price EW; Carnazza KE; Carlin SD; Cho A; Edwards KJ; Sevak KK; Glaser JM; de Stanchina E; Janjigian YY; Lewis JS
    J Nucl Med; 2017 Sep; 58(9):1386-1394. PubMed ID: 28280216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiosynthesis and Preclinical Evaluation of
    Gröner B; Hoffmann C; Endepols H; Urusova EA; Brugger M; Neumaier F; Timmer M; Neumaier B; Zlatopolskiy BD
    Mol Pharm; 2024 Jun; 21(6):2795-2812. PubMed ID: 38747353
    [No Abstract]   [Full Text] [Related]  

  • 10.
    Fung K; Vivier D; Keinänen O; Sarbisheh EK; Price EW; Zeglis BM
    Molecules; 2020 May; 25(10):. PubMed ID: 32429033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distribution of LAT1-targeting PET tracer was independent of the tumor blood flow in rat xenograft models of C6 glioma and MIA PaCa-2.
    Aoki M; Watabe T; Nagamori S; Naka S; Ikeda H; Kongpracha P; Horitsugi G; Kanai Y; Shimosegawa E; Kanai Y; Hatazawa J
    Ann Nucl Med; 2019 Jun; 33(6):394-403. PubMed ID: 30820863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PET Imaging of L-Type Amino Acid Transporter (LAT1) and Cystine-Glutamate Antiporter (x
    Krys D; Mattingly S; Glubrecht D; Wuest M; Wuest F
    Mol Imaging Biol; 2020 Dec; 22(6):1562-1571. PubMed ID: 32789819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New fluoroethyl phenylalanine analogues as potential LAT1-targeting PET tracers for glioblastoma.
    Verhoeven J; Hulpia F; Kersemans K; Bolcaen J; De Lombaerde S; Goeman J; Descamps B; Hallaert G; Van den Broecke C; Deblaere K; Vanhove C; Van der Eycken J; Van Calenbergh S; Goethals I; De Vos F
    Sci Rep; 2019 Feb; 9(1):2878. PubMed ID: 30814660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Light-Induced Radiosynthesis of
    Klingler S; Fay R; Holland JP
    J Nucl Med; 2020 Jul; 61(7):1072-1078. PubMed ID: 31924725
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Watabe T; Ikeda H; Nagamori S; Wiriyasermkul P; Tanaka Y; Naka S; Kanai Y; Hagiwara K; Aoki M; Shimosegawa E; Kanai Y; Hatazawa J
    Eur J Nucl Med Mol Imaging; 2017 Feb; 44(2):321-331. PubMed ID: 27550420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Site-specifically labeled
    Kristensen LK; Christensen C; Jensen MM; Agnew BJ; Schjöth-Frydendahl C; Kjaer A; Nielsen CH
    Theranostics; 2019; 9(15):4409-4420. PubMed ID: 31285769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of Next-Generation Anti-CD20 Antibodies Labeled with
    Yoon JT; Longtine MS; Marquez-Nostra BV; Wahl RL
    J Nucl Med; 2018 Aug; 59(8):1219-1224. PubMed ID: 29348316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specific transport of 3-fluoro-l-α-methyl-tyrosine by LAT1 explains its specificity to malignant tumors in imaging.
    Wei L; Tominaga H; Ohgaki R; Wiriyasermkul P; Hagiwara K; Okuda S; Kaira K; Oriuchi N; Nagamori S; Kanai Y
    Cancer Sci; 2016 Mar; 107(3):347-52. PubMed ID: 26749017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ImmunoPET imaging of renal cell carcinoma with (124)I- and (89)Zr-labeled anti-CAIX monoclonal antibody cG250 in mice.
    Stillebroer AB; Franssen GM; Mulders PF; Oyen WJ; van Dongen GA; Laverman P; Oosterwijk E; Boerman OC
    Cancer Biother Radiopharm; 2013 Sep; 28(7):510-5. PubMed ID: 23697926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of Anti-LGR5 Antibodies by ImmunoPET for Imaging Colorectal Tumors and Development of Antibody-Drug Conjugates.
    Azhdarinia A; Voss J; Ghosh SC; Simien JA; Hernandez Vargas S; Cui J; Yu WA; Liu Q; Carmon KS
    Mol Pharm; 2018 Jun; 15(6):2448-2454. PubMed ID: 29718672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.